Genprex, Inc. (GNPX)
NASDAQ: GNPX · IEX Real-Time Price · USD
1.970
+0.070 (3.68%)
At close: Jul 2, 2024, 4:00 PM
1.990
+0.020 (1.02%)
After-hours: Jul 2, 2024, 4:25 PM EDT
Genprex Market Cap
Genprex has a market cap or net worth of $4.13 million as of July 2, 2024. Its market cap has decreased by -89.23% in one year.
Market Cap
4.13M
Enterprise Value
-4.08M
1-Year Change
-89.23%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $11.30M to $4.13M, a decrease of -63.41%. That is a compound annual growth rate of -14.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 4.10M | -70.07% |
| Dec 29, 2023 | 13.70M | -80.32% |
| Dec 30, 2022 | 69.60M | 11.18% |
| Dec 31, 2021 | 62.60M | -61.92% |
| Dec 31, 2020 | 164.40M | 3,123.53% |
| Dec 31, 2019 | 5.10M | -69.28% |
| Dec 31, 2018 | 16.60M | 46.90% |
| Mar 29, 2018 | 11.30M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 4.08M |
| iSpecimen | 4.04M |
| Sonoma Pharmaceuticals | 4.03M |
| Protagenic Therapeutics | 4.03M |
| Trevena | 4.00M |
| China Pharma Holdings | 3.94M |
| Ensysce Biosciences | 3.84M |
| Assure Holdings | 3.81M |